SCHEMBL2127691

SCHEMBL2127691

COc1c(C=Cc2ccc(NS(C)(=O)=O)cc2)cc(-c2ccc[nH]c2=O)cc1CC(F)(F)F

nearest known ligand 0.73

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.73
TRPV1 Q8NER1 4/20 0.35
NFE2L2 Q16236 1/20 0.33
PDPK1 O15530 1/20 0.33
KIF11 P52732 2/20 0.32
ABL1 P00519 2/20 0.32
PADI4 Q9UM07 1/20 0.31
JAK2 O60674 1/20 0.31
JAK1 P23458 1/20 0.31
TYK2 P29597 1/20 0.31
JAK3 P52333 1/20 0.31
CYP17A1 P05093 1/20 0.31
PIP4K2A P48426 1/20 0.31
PIP4K2B P78356 1/20 0.31
PIP4K2C Q8TBX8 1/20 0.31
BRD4 O60885 1/20 0.31
EP300 Q09472 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1542959 1.00 CYP3A4 (0.73) CYP3A4TRPV1NFE2L2PDPK1KIF11
SCHEMBL2128091 0.87 CYP3A4 (0.85) CYP3A4TRPV1NFE2L2PDPK1KIF11
SCHEMBL1543113 0.87 CYP3A4 (0.85) CYP3A4TRPV1NFE2L2PDPK1KIF11
SCHEMBL2510674 0.86 CYP3A4 (0.54) CYP3A4TRPV1KIF11ABL1PADI4
SCHEMBL2510672 0.86 CYP3A4 (0.54) CYP3A4TRPV1KIF11ABL1PADI4
SCHEMBL2128074 0.84 CYP3A4 (1.00) CYP3A4TRPV1PDPK1PADI4JAK2
SCHEMBL2128077 0.84 CYP3A4 (1.00) CYP3A4TRPV1PDPK1PADI4JAK2
SCHEMBL2128895 0.83 CYP3A4 (0.81) CYP3A4TRPV1NFE2L2PDPK1KIF11
SCHEMBL1542989 0.83 CYP3A4 (0.81) CYP3A4TRPV1NFE2L2PDPK1KIF11
SCHEMBL2127937 0.83 CYP3A4 (0.87) CYP3A4TRPV1PDPK1PADI4JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8273773-B2 Heterocyclic antiviral compounds ROCHE PALO ALTO LLC (US) 2012-09-25 US claimed
EP-2307372-B1 HETEROCYCLIC ANTIVIRAL COMPOUNDS HOFFMANN LA ROCHE (CH) 2012-04-25 EP claimed